Literature DB >> 15554423

Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach.

Sara Montagnese1, Piero Amodio, Marsha Y Morgan.   

Abstract

There is no "gold standard" for diagnosing hepatic encephalopathy in patients with cirrhosis. In consequence, the presence of this condition, unless floridly overt, is often missed. As a result, the majority of patients are denied the benefits of treatment. There are a number of individual techniques, which access different aspects of cerebral function that can be used, singly or in combination, to provide diagnostic information in this condition, including mental state assessment, psychometric testing, electroencephalography, sensory and cognitive evoked potentials, and neuroimaging. These have been variously applied to the study of hepatic encephalopathy but fundamental differences in the essential aims of the studies, as well as differences in the patient populations and the acquisition and analysis of the data, have made comparisons difficult. Thus, there is no clear consensus as to the sensitivity, specificity, or validity of these tests when used alone or in combination. There are, however, a number of additional methods that could be used to analyze the electrophysiological data, and a number of alternative evoked potentials that could be measured to provide better diagnostic information. In addition, there are a number of techniques, such as critical flicker frequency and smooth pursuit eye movements, which have not yet been applied systematically in this condition and which may provide useful diagnostic information. Clearly the methods for assessing hepatic encephalopathy need to be reviewed, newer methods for analyzing the electrophysiological data and newer techniques for assessing alternative aspects of cerebral function need to be explored for their diagnostic utility. This process should aim at developing a multidimensional diagnostic tool.

Entities:  

Mesh:

Year:  2004        PMID: 15554423     DOI: 10.1023/b:mebr.0000043977.11113.2a

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  150 in total

1.  A novel spatio-temporal decomposition of the EEG: derivation, validation and clinical application.

Authors:  Clive Jackson; Michael Sherratt
Journal:  Clin Neurophysiol       Date:  2004-01       Impact factor: 3.708

Review 2.  EEG and event related potentials in hepatic encephalopathy.

Authors:  M G Davies; M J Rowan; J Feely
Journal:  Metab Brain Dis       Date:  1991-12       Impact factor: 3.584

3.  Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy.

Authors:  C L Yen; Y F Liaw
Journal:  Hepatogastroenterology       Date:  1990-06

4.  Evoked potentials in assessment and follow-up of patients with Wilson's disease.

Authors:  G Grimm; W Oder; L Prayer; P Ferenci; C Madl
Journal:  Lancet       Date:  1990-10-20       Impact factor: 79.321

5.  The use of the visual evoked potential (VEP) in delineating a state of subclinical encephalopathy. A comparison with the number connection test (NCT).

Authors:  L J Levy; R P Bolton; M S Losowsky
Journal:  J Hepatol       Date:  1987-10       Impact factor: 25.083

6.  Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia.

Authors:  M Demedts; E Pillen; J De Groote; K P Van de Woestijne
Journal:  Acta Neurol Belg       Date:  1973 Sep-Oct       Impact factor: 2.396

7.  Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy.

Authors:  K M de Bruijn; L M Blendis; D H Zilm; P L Carlen; G H Anderson
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

8.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

9.  Evoked potentials for the evaluation of latent hepatic encephalopathy in pediatric liver transplant candidates.

Authors:  D B Nora; O B Amaral; J V Busnello; J Quevedo; S Vieira; T R da Silveira; F Kapczinski
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-10       Impact factor: 2.839

Review 10.  Cerebral changes in hepatic encephalopathy.

Authors:  A Watanabe
Journal:  J Gastroenterol Hepatol       Date:  1998-07       Impact factor: 4.029

View more
  36 in total

Review 1.  Neurophysiological investigation of hepatic encephalopathy.

Authors:  Piero Amodio; Angelo Gatta
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

2.  P300 cognitive evoked potentials before and after liver transplantation.

Authors:  Roy R Reeves; Frederick A Struve; Carla J Rash; Randy S Burke
Journal:  Metab Brain Dis       Date:  2007-04-25       Impact factor: 3.584

Review 3.  Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.

Authors:  Lise L Gluud; Rebecca Jeyaraj; Marsha Y Morgan
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 4.  Current and future diagnosis of hepatic encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Metab Brain Dis       Date:  2010-03-06       Impact factor: 3.584

5.  Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2011-04-12       Impact factor: 3.584

Review 6.  Useful tests for hepatic encephalopathy in clinical practice.

Authors:  Eiman Nabi; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2014-01

7.  Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.

Authors:  Harry D Zacharias; Antony P Zacharias; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

8.  A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.

Authors:  Hanaa Mostafa El-Karaksy; Omneya Afifi; Azza Bakry; Ann Abdel Kader; Noha Saber
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

Review 9.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Lise Lotte Gluud; Hendrik Vilstrup; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

10.  Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA).

Authors:  Tarek I Hassanein; Robin C Hilsabeck; William Perry
Journal:  Dig Dis Sci       Date:  2007-08-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.